Ning Li

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 34

Top Topics

Top Venues

Journal of translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Bolun Zhou, Fan Zhang, Wei Guo, Shuhang Wang, Ning Li, Bin Qiu, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Fang Lv, Shugeng Gao
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside. Journal of translational medicine 22 (1) (2024)
Shuhang Wang, Yale Jiang, Rongshou Zheng, Yue Yu, Wen-Qiang Wei, Ning Li
Mobilizing China and the Global Community to Confront the Treatment Desert for Pediatric Solid Tumors. Cancer discovery 14 (1) (2024)
Guo Zhao, Yuning Wang, Shuhang Wang, Ning Li
Comprehensive multi-omics analysis provides biological insights and therapeutic strategies for small-cell lung cancer. MedComm 5 (6) (2024)
Guo Zhao, Yuning Wang, Shuhang Wang, Ning Li
Reporting outcome comparisons by sex in oncology clinical trials. Nature communications 15 (1) (2024)
Shuhang Wang, Yale Jiang, Rongshou Zheng, Yue Yu, Wen-Qiang Wei, Ning Li
Mobilizing China and the Global Community to Confront the Treatment Desert for Pediatric Solid Tumors. Cancer discovery 14 (1) (2024)
Guo Zhao, Yuning Wang, Shuhang Wang, Ning Li
Reporting outcome comparisons by sex in oncology clinical trials. Nature communications 15 (1) (2024)
Guo Zhao, Yuning Wang, Shuhang Wang, Ning Li
Reporting outcome comparisons by sex in oncology clinical trials. Nature communications 15 (1) (2024)
Jiawei Zhou, Guo Zhao, Shuhang Wang, Ning Li
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade. British journal of cancer (2024)
Jiatong Ding, Yale Jiang, Jiawei Zhou, Qiyu Tang, Shujun Xing, Shuhang Wang, Ning Li
The global landscape of clinical trials and drug discovery for brain metastasis. Journal of translational medicine 22 (1) (2024)
Jiatong Ding, Yale Jiang, Jiawei Zhou, Qiyu Tang, Shujun Xing, Shuhang Wang, Ning Li
The global landscape of clinical trials and drug discovery for brain metastasis. Journal of translational medicine 22 (1) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function. MedComm 5 (5) (2024)
Bolun Zhou, Fan Zhang, Wei Guo, Shuhang Wang, Ning Li, Bin Qiu, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Fang Lv, Shugeng Gao
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function. MedComm 5 (5) (2024)
Guo Zhao, Yuanting Cai, Yuning Wang, Yuan Fang, Shuhang Wang, Ning Li
Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study. The journal of gene medicine 26 (5) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function. MedComm 5 (5) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside. Journal of translational medicine 22 (1) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside. Journal of translational medicine 22 (1) (2024)
Jiatong Ding, Yale Jiang, Jiawei Zhou, Qiyu Tang, Shujun Xing, Shuhang Wang, Ning Li
The global landscape of clinical trials and drug discovery for brain metastasis. Journal of translational medicine 22 (1) (2024)
Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li
DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside. Journal of translational medicine 22 (1) (2024)
Guo Zhao, Yuning Wang, Shuhang Wang, Ning Li
Comprehensive multi-omics analysis provides biological insights and therapeutic strategies for small-cell lung cancer. MedComm 5 (6) (2024)
Bolun Zhou, Fan Zhang, Wei Guo, Shuhang Wang, Ning Li, Bin Qiu, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Fang Lv, Shugeng Gao
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Xin Wang, Yicheng Liang, Yuanzhuo Wang, Xiangzhi Meng, Boxuan Zhou, Zhenyi Xu, Hui Wang, Wenjing Yang, Ning Li, Yushun Gao, Jie He, null null
Outcomes and prognosis of non-small cell lung cancer patients who underwent curable surgery: a protocol for a real-world, retrospective, population-based and nationwide Chinese National Lung Cancer Cohort (CNLCC) study. BMJ open 13 (6) (2023)
Qian Zhang, Xiuli Tao, Pei Yuan, Zewei Zhang, Jianming Ying, Lei Guo, Ning Li, Shuhang Wang, Jing Li, Ying Liu, Wei Guo, Shijun Zhao, Ning Wu
Predictive value of 18 F-FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non-small cell lung cancer. Cancer medicine (2023)
Xin Wang, Yicheng Liang, Yuanzhuo Wang, Xiangzhi Meng, Boxuan Zhou, Zhenyi Xu, Hui Wang, Wenjing Yang, Ning Li, Yushun Gao, Jie He, null null
Outcomes and prognosis of non-small cell lung cancer patients who underwent curable surgery: a protocol for a real-world, retrospective, population-based and nationwide Chinese National Lung Cancer Cohort (CNLCC) study. BMJ open 13 (6) (2023)
Qian Zhang, Xiuli Tao, Shijun Zhao, Ning Li, Shuhang Wang, Ning Wu
Association of Clinical and Radiological Features with Disease Severity of Symptomatic Immune Checkpoint Inhibitor-Related Pneumonitis. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Xin Wang, Yicheng Liang, Yuanzhuo Wang, Xiangzhi Meng, Boxuan Zhou, Zhenyi Xu, Hui Wang, Wenjing Yang, Ning Li, Yushun Gao, Jie He, null null
Outcomes and prognosis of non-small cell lung cancer patients who underwent curable surgery: a protocol for a real-world, retrospective, population-based and nationwide Chinese National Lung Cancer Cohort (CNLCC) study. BMJ open 13 (6) (2023)
Qian Zhang, Xiuli Tao, Shijun Zhao, Ning Li, Shuhang Wang, Ning Wu
Association of Clinical and Radiological Features with Disease Severity of Symptomatic Immune Checkpoint Inhibitor-Related Pneumonitis. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Shuhang Wang, Yale Jiang, Huilei Miao, Yuan Fang, Ning Jiang, Yue Yu, Peiwen Ma, Qiyu Tang, Dandan Cui, Hong Fang, Huiyao Huang, Qi Fan, Chao Sun, Anqi Yu, Shuangman Miao, Jingting Du, Jingxiao Zhu, Yuning Wang, Ning Li
Targeting rare tumors: new focus for clinical research in China. EMBO molecular medicine (2022)
Dawei Wu, Huiyao Huang, Minghui Zhang, Ziwei Li, Shuhang Wang, Yue Yu, Yuan Fang, Ning Jiang, Huilei Miao, Peiwen Ma, Yu Tang, Ning Li
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials. Journal of hematology & oncology 15 (1) (2022)
Shuhang Wang, Yuqi Yang, Lu Li, Peiwen Ma, Yale Jiang, Minghui Ge, Yue Yu, Huiyao Huang, Yuan Fang, Ning Jiang, Huilei Miao, Hao Guo, Linlin Yan, Yong Ren, Lichao Sun, Yan Zha, Ning Li
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development. Vaccines 10 (8) (2022)
Shuhang Wang, Hui-Yao Huang, Dawei Wu, Hong Fang, Jianming Ying, Ying Bai, Yue Yu, Yuan Fang, Ning Jiang, Chao Sun, Anqi Yu, Qi Fan, Shujun Xing, Yufen Ni, Wei Zhang, Chenhua Wu, Xinqian Ji, Hui Wang, Yaqian Guo, Qiyu Tang, Yuan Wang, Yu Tang, Ning Li
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours. BMJ open 11 (6) (2021)
Shuhang Wang, Kun Chen, Qi Lei, Peiwen Ma, Andy Qingan Yuan, Yong Zhao, Youwei Jiang, Hong Fang, Shujun Xing, Yuan Fang, Ning Jiang, Huilei Miao, Minghui Zhang, Shujun Sun, Zicheng Yu, Wei Tao, Qi Zhu, Yingjie Nie, Ning Li
The state of the art of bispecific antibodies for treating human malignancies. EMBO molecular medicine 13 (9) (2021)
Yuan Li, Long Wu, Weiping Tao, Dawei Wu, Zongbi Yi, Ning Li
Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors. BioMed research international 2020 (2020)